Plus Therapeutics (PSTV) Free Cash Flow (2010 - 2026)
Plus Therapeutics (PSTV) reported Free Cash Flow of -$7.1 million for Q1 2026, down 14.27% year-over-year from -$8.2 million in Q1 2025, and down 11.91% quarter-over-quarter from -$6.3 million in Q4 2025.
Plus Therapeutics (PSTV) Free Cash Flow (2010 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 17 years of Free Cash Flow data on file, last reported at -$7.1 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$7.1 million, down 14.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$21.7 million (down 76.29% YoY), and the FY2025 annual result was -$20.8 million, down 94.79% from the prior year.
- Free Cash Flow fell to -$7.1 million in Q1 2026 per PSTV's latest filing, from -$6.3 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$1.2 million in Q4 2024 and troughed at -$7.1 million in Q1 2026.
- A 5-year average of -$3.8 million and a median of -$3.7 million in 2024 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2024 and 2025: Free Cash Flow soared 55.86% in 2024, then tumbled 415.96% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$2.4 million in 2022, then climbed by 18.59% to -$1.9 million in 2023, then soared by 36.45% to -$1.2 million in 2024, then plunged by 415.96% to -$6.3 million in 2025, then declined by 11.91% to -$7.1 million in 2026.
- Business Quant data shows PSTV's Free Cash Flow at -$7.1 million in Q1 2026, -$6.3 million in Q4 2025, and -$2.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 63,220.27 |
| 10 | Plus Therapeutics | 34.26 Mn | 19.15 Mn | - | -7.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.06 Mn |
| Mar 31, 2026 | -7.06 Mn |
| Dec 31, 2025 | -6.31 Mn |
| Dec 31, 2025 | -6.31 Mn |
| Sep 30, 2025 | -2.56 Mn |
| Sep 30, 2025 | -2.56 Mn |
| Jun 30, 2025 | -5.81 Mn |
| Jun 30, 2025 | -5.81 Mn |
| Mar 31, 2025 | -6.18 Mn |
| Mar 31, 2025 | -6.18 Mn |
| Dec 31, 2024 | -1.22 Mn |
| Dec 31, 2024 | -1.22 Mn |
| Sep 30, 2024 | -3.69 Mn |
| Sep 30, 2024 | -3.69 Mn |
| Jun 30, 2024 | -1.23 Mn |
| Jun 30, 2024 | -1.23 Mn |
| Mar 31, 2024 | -4.55 Mn |
| Mar 31, 2024 | -4.55 Mn |
| Dec 31, 2023 | -1.92 Mn |
| Dec 31, 2023 | -1.92 Mn |